Bristol Myers Squibb EBITDA Margin 2006-2021 | BMY

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Bristol Myers Squibb (BMY) over the last 10 years. The current EBITDA margin for Bristol Myers Squibb as of September 30, 2021 is .
Bristol Myers Squibb EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2021-09-30 $45.47B $6.59B 14.48%
2021-06-30 $44.38B $6.61B 14.90%
2021-03-31 $42.81B $6.53B 15.26%
2020-12-31 $42.52B $3.51B 8.25%
2020-09-30 $39.40B $12.38B 31.42%
2020-06-30 $34.86B $8.99B 25.77%
2020-03-31 $31.01B $6.75B 21.75%
2019-12-31 $26.15B $6.72B 25.71%
2019-09-30 $24.17B $7.29B 30.16%
2019-06-30 $23.86B $8.10B 33.96%
2019-03-31 $23.29B $6.83B 29.34%
2018-12-31 $22.56B $6.61B 29.28%
2018-09-30 $22.04B $5.82B 26.42%
2018-06-30 $21.60B $4.86B 22.51%
2018-03-31 $21.04B $5.69B 27.06%
2017-12-31 $20.78B $5.92B 28.49%
2017-09-30 $20.57B $6.23B 30.30%
2017-06-30 $20.24B $6.53B 32.25%
2017-03-31 $19.97B $6.73B 33.68%
2016-12-31 $19.43B $6.30B 32.41%
2016-09-30 $18.47B $4.76B 25.74%
2016-06-30 $17.62B $4.18B 23.74%
2016-03-31 $16.91B $2.62B 15.50%
2015-12-31 $16.56B $2.45B 14.81%
2015-09-30 $16.53B $2.83B 17.12%
2015-06-30 $16.38B $2.86B 17.44%
2015-03-31 $16.11B $3.20B 19.85%
2014-12-31 $15.88B $2.85B 17.94%
2014-09-30 $16.06B $3.86B 24.00%
2014-06-30 $16.21B $3.73B 23.03%
2014-03-31 $16.37B $3.97B 24.25%
2013-12-31 $16.39B $3.65B 22.30%
2013-09-30 $16.14B $3.61B 22.36%
2013-06-30 $15.81B $3.38B 21.36%
2013-03-31 $16.20B $3.86B 23.85%
2012-12-31 $17.62B $5.14B 29.19%
2012-09-30 $18.88B $6.00B 31.78%
2012-06-30 $20.49B $7.09B 34.59%
2012-03-31 $21.48B $7.86B 36.57%
2011-12-31 $21.24B $7.61B 35.82%
2011-09-30 $20.90B $7.40B 35.41%
2011-06-30 $20.35B $7.30B 35.85%
2011-03-31 $19.69B $7.04B 35.78%
2010-12-31 $19.48B $6.68B 34.27%
2010-09-30 $19.41B $6.46B 33.28%
2010-06-30 $19.40B $6.37B 32.83%
2010-03-31 $19.29B $6.24B 32.35%
2009-12-31 $18.81B $6.03B 32.04%
2009-09-30 $16.14B $5.08B 31.48%
2009-06-30 $16.61B $4.65B 28.01%
2009-03-31 $17.15B $4.36B 25.44%
2008-12-31 $17.72B $4.33B 24.43%
2008-09-30 $17.58B $3.80B 21.63%
2008-06-30 $16.92B $3.66B 21.60%
2008-03-31 $16.19B $3.41B 21.07%
2007-12-31 $15.62B $3.09B 19.75%
2007-09-30 $15.90B $2.78B 17.51%
2007-06-30 $15.45B $2.42B 15.68%
2007-03-31 $15.85B $2.57B 16.23%
2006-12-31 $16.21B $2.70B 16.65%
2006-09-30 $18.12B $4.03B 22.26%
2006-06-30 $18.73B $4.47B 23.86%
2006-03-31 $18.75B $4.51B 24.04%
2005-12-31 $18.61B $4.63B 24.89%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $141.747B $42.518B
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes and sells biopharmaceutical products. It offers products which includes hematology, oncology, cardiovascular and immunology. Bristol-Myers Squibb Company, formerly known as Bristol-Myers Company, is based in New York.
Stock Name Country Market Cap PE Ratio
Bio-Rad Laboratories (BIO.B) United States $17.038B 34.58
QIAGEN (QGEN) Netherlands $10.791B 18.27
Biohaven Pharmaceutical Holding (BHVN) United States $7.896B 0.00
Emergent Biosolutions (EBS) United States $2.380B 8.56
Arcus Biosciences (RCUS) United States $2.057B 0.00
Myovant Sciences (MYOV) United Kingdom $1.157B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.011B 0.00
Zymeworks (ZYME) Canada $0.386B 0.00
Ambrx Biopharma (AMAM) United States $0.188B 0.00
SQZ Biotechnologies (SQZ) United States $0.178B 0.00
Enzo Biochem (ENZ) United States $0.154B 19.88